acetazolamide has been researched along with Injury, Ischemia-Reperfusion in 7 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ischemia reperfusion injury (IRI) is a primary concern in liver transplantation, especially when steatosis is present." | 5.42 | Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury. ( Bejaoui, M; C T, S; Capasso, C; De Luca, V; Folch-Puy, E; Panisello, A; Pantazi, E; Rosselló-Catafau, J; Serafin, A, 2015) |
| "Hyperperfusion syndrome is a rare but potentially devastating complication after carotid endarterectomy (CEA)." | 2.70 | Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. ( Fujita, S; Hosoda, K; Kamei, M; Kawaguchi, T; Kidoguchi, K; Koyama, J; Shibata, Y; Tamaki, N, 2001) |
| "Ischemia reperfusion injury (IRI) is a primary concern in liver transplantation, especially when steatosis is present." | 1.42 | Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury. ( Bejaoui, M; C T, S; Capasso, C; De Luca, V; Folch-Puy, E; Panisello, A; Pantazi, E; Rosselló-Catafau, J; Serafin, A, 2015) |
| "Young patients with moyamoya disease frequently exhibit extensive cerebral infarction at the time of initial presentation, and even in the early postoperative period." | 1.36 | Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. ( Fujimura, M; Hayashi, T; Shirane, R; Tominaga, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y | 1 |
| Zhang, JZ | 1 |
| Han, J | 1 |
| Yang, HP | 1 |
| Tie, L | 1 |
| Yang, XY | 1 |
| Xiaokaiti, Y | 1 |
| Pan, Y | 1 |
| Li, XJ | 1 |
| Andringa, KK | 1 |
| Agarwal, A | 1 |
| Bejaoui, M | 1 |
| Pantazi, E | 1 |
| De Luca, V | 1 |
| Panisello, A | 1 |
| Folch-Puy, E | 1 |
| Serafin, A | 1 |
| Capasso, C | 1 |
| C T, S | 1 |
| Rosselló-Catafau, J | 1 |
| Hayashi, T | 1 |
| Shirane, R | 1 |
| Fujimura, M | 1 |
| Tominaga, T | 1 |
| Maruki, Y | 1 |
| Koehler, RC | 1 |
| Eleff, SM | 1 |
| Traystman, RJ | 1 |
| Sbarigia, E | 1 |
| Speziale, F | 1 |
| Giannoni, MF | 1 |
| Colonna, M | 1 |
| Panico, MA | 1 |
| Fiorani, P | 1 |
| Hosoda, K | 1 |
| Kawaguchi, T | 1 |
| Shibata, Y | 1 |
| Kamei, M | 1 |
| Kidoguchi, K | 1 |
| Koyama, J | 1 |
| Fujita, S | 1 |
| Tamaki, N | 1 |
1 review available for acetazolamide and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Role of hypoxia-inducible factors in acute kidney injury.
Topics: Acetazolamide; Acute Kidney Injury; Adaptation, Physiological; Altitude; Animals; Barbiturates; Basi | 2014 |
1 trial available for acetazolamide and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy.
Topics: Acetazolamide; Aged; Brain; Carotid Artery, Internal; Cerebrovascular Circulation; Endarterectomy, C | 2001 |
5 other studies available for acetazolamide and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Hypoxia-inducible factor-1α dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury.
Topics: Acetazolamide; Animals; Apoptosis; Cells, Cultured; Gene Knockdown Techniques; Humans; Hydrogen Pero | 2013 |
Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury.
Topics: Acetazolamide; Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cold Temperature; Enzy | 2015 |
Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Topics: Acetazolamide; Adolescent; Aphasia; Brain; Brain Edema; Cerebral Angiography; Cerebral Infarction; C | 2010 |
Intracellular pH during reperfusion influences evoked potential recovery after complete cerebral ischemia.
Topics: Acetazolamide; Acidosis; Animals; Bicarbonates; Brain Ischemia; Carbon Dioxide; Cytoplasm; Dogs; Evo | 1993 |
Post-carotid endarterectomy hyperperfusion syndrome: preliminary observations for identifying at risk patients by transcranial Doppler sonography and the acetazolamide test.
Topics: Acetazolamide; Aged; Blood-Brain Barrier; Brain; Brain Edema; Carotid Artery, Internal; Carotid Sten | 1993 |